Evolus (EOLS)
(Real Time Quote from BATS)
$13.09 USD
+0.32 (2.51%)
Updated May 15, 2024 12:41 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Income Statements
Fiscal Year end for Evolus, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 202 | 149 | 100 | 57 | 35 |
Cost Of Goods | 62 | 56 | 44 | 18 | 8 |
Gross Profit | 141 | 93 | 56 | 38 | 27 |
Selling & Adminstrative & Depr. & Amort Expenses | 190 | 158 | 101 | 191 | 126 |
Income After Depreciation & Amortization | -49 | -65 | -44 | -153 | -99 |
Non-Operating Income | 2 | 0 | -1 | 1 | 2 |
Interest Expense | 14 | 9 | 1 | 11 | 8 |
Pretax Income | -62 | -74 | -47 | -163 | -105 |
Income Taxes | 0 | 0 | 0 | 0 | -15 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -62 | -74 | -47 | -163 | -90 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -62 | -74 | -47 | -163 | -90 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -42 | -60 | -37 | -143 | -93 |
Depreciation & Amortization (Cash Flow) | 7 | 6 | 8 | 10 | 6 |
Income After Depreciation & Amortization | -49 | -65 | -44 | -153 | -99 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 56.92 | 56.07 | 49.77 | 33.74 | 28.24 |
Diluted EPS Before Non-Recurring Items | -0.95 | -1.17 | -0.94 | -2.27 | -3.19 |
Diluted Net EPS (GAAP) | -1.08 | -1.33 | -0.94 | -4.83 | -3.19 |
Fiscal Year end for Evolus, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 59.33 | 61.00 | 50.02 | 49.35 | 41.72 |
Cost Of Goods | 18.07 | 19.27 | 15.43 | 14.71 | 12.15 |
Gross Profit | 41.27 | 41.73 | 34.59 | 34.63 | 29.58 |
SG&A, R&D, and Dept/Amort Expenses | 50.19 | 50.36 | 48.03 | 49.76 | 41.61 |
Income After SG&A, R&D, and Dept/Amort Expenses | -8.92 | -8.63 | -13.44 | -15.13 | -12.03 |
Non-Operating Income | 0.56 | 0.99 | 0.33 | 0.18 | 0.06 |
Interest Expense | 4.70 | 4.07 | 3.79 | 3.18 | 2.79 |
Pretax Income | -13.06 | -11.73 | -16.90 | -18.12 | -14.77 |
Income Taxes | 0.05 | 0.11 | 0.02 | 0.02 | 0.02 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -13.11 | -11.83 | -16.92 | -18.14 | -14.79 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -13.11 | -11.83 | -16.92 | -18.14 | -14.79 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 58.80 | 57.25 | 57.02 | 56.92 | 56.48 |
Diluted EPS Before Non-Recurring Items | -0.20 | -0.20 | -0.26 | -0.28 | -0.24 |
Diluted Net EPS (GAAP) | -0.22 | -0.20 | -0.30 | -0.32 | -0.26 |